Literature DB >> 20009057

Association between carrier screening and incidence of cystic fibrosis.

Carlo Castellani1, Luigi Picci, Anna Tamanini, Paolo Girardi, Paolo Rizzotti, Baroukh Maurice Assael.   

Abstract

CONTEXT: A downward trend in cystic fibrosis (CF) birth incidence has been reported in some areas.
OBJECTIVE: To evaluate the association between carrier screening and CF birth incidence. DESIGN, SETTING, AND PARTICIPANTS: In northeastern Italy, CF birth incidence is monitored by means of a long-standing neonatal screening program. In the same area, 2 sections using different carrier detection approaches were identified--the western region, in which CF carrier tests are offered only to relatives of patients or to couples planning in vitro fertilization; and the eastern region, in which carrier testing is offered to relatives and carrier screening to infertile couples and to couples of reproductive age. A total of 779,631 newborns underwent CF neonatal screening between January 1993 and December 2007, of whom 195 had CF detected. MAIN OUTCOME MEASURE: Cystic fibrosis birth incidence in the 2 regions.
RESULTS: A time-related decrease in birth incidence was found, with a mean annual percentage decrease of 0.16 per 10,000 neonates (P < .001). In the western region, 2559 carrier tests were performed, 314 carriers were identified, and 9 carrier couples were detected. In the eastern region, 87,025 carrier tests were performed, 3650 carriers were identified, and 82 carrier couples were detected. The birth rate decrease was greater in the eastern region (decrease rate, 0.24; 95% confidence interval [CI], 0.12-0.36) than in the western region (decrease rate, 0.04; 95% CI, -0.16 to 0.08; P = .01). The increase in the number of screened carriers over time was significantly correlated with the decrease in CF birth incidence (correlation coefficient = -0.53; 95% CI, -0.20 to -0.74; P = .003).
CONCLUSION: In northeastern Italy, carrier screening was associated with a decrease in the incidence of CF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009057     DOI: 10.1001/jama.2009.1758

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

1.  A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors:  Janelle Wells; Marjorie Rosenberg; Gary Hoffman; Michael Anstead; Philip M Farrell
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

Review 2.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

3.  Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.

Authors:  Tommaso Bruni; Matteo Mameli; Gabriella Pravettoni; Giovanni Boniolo
Journal:  Med Health Care Philos       Date:  2012-08

Review 4.  Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Jessica E Pittman; Garry Cutting; Stephanie D Davis; Thomas Ferkol; Richard Boucher
Journal:  Ann Am Thorac Soc       Date:  2014-04

5.  Carrier testing for severe childhood recessive diseases by next-generation sequencing.

Authors:  Callum J Bell; Darrell L Dinwiddie; Neil A Miller; Shannon L Hateley; Elena E Ganusova; Joann Mudge; Ray J Langley; Lu Zhang; Clarence C Lee; Faye D Schilkey; Vrunda Sheth; Jimmy E Woodward; Heather E Peckham; Gary P Schroth; Ryan W Kim; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2011-01-12       Impact factor: 17.956

Review 6.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

7.  Changing incidence of cystic fibrosis in Wisconsin, USA.

Authors:  Katelyn Parker-McGill; Melodee Nugent; Rachel Bersie; Gary Hoffman; Michael Rock; Mei Baker; Philip M Farrell; Pippa Simpson; Hara Levy
Journal:  Pediatr Pulmonol       Date:  2015-08-10

Review 8.  Genetics of Male Infertility.

Authors:  Filipe Tenorio Lira Neto; Phil Vu Bach; Bobby Baback Najari; Philip Shihua Li; Marc Goldstein
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

9.  Screening for cystic fibrosis in New York State: considerations for algorithm improvements.

Authors:  Denise M Kay; Breanne Maloney; Rhonda Hamel; Melissa Pearce; Lenore DeMartino; Rebecca McMahon; Emily McGrath; Lea Krein; Beth Vogel; Carlos A Saavedra-Matiz; Michele Caggana; Norma P Tavakoli
Journal:  Eur J Pediatr       Date:  2015-08-21       Impact factor: 3.183

10.  Cystic fibrosis carrier screening effects on birth prevalence and newborn screening.

Authors:  Carlo Castellani; Luigi Picci; Gloria Tridello; Elia Casati; Anna Tamanini; Lucia Bartoloni; Maurizio Scarpa; Baroukh M Assael
Journal:  Genet Med       Date:  2015-06-18       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.